End-of-day quote
NSE India S.E.
06:08:04 2020-02-11 am EST
|
5-day change
|
1st Jan Change
|
1,004
INR
|
+1.00%
|
|
-0.81%
|
+1.25%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
84,482
|
79,081
|
143,890
|
200,641
|
185,866
|
168,659
|
-
|
-
|
Enterprise Value (EV)
1 |
84,482
|
76,251
|
141,895
|
200,507
|
183,230
|
168,672
|
168,691
|
168,899
|
P/E ratio
|
29.9
x
|
23.7
x
|
53.4
x
|
57.9
x
|
40.6
x
|
53.3
x
|
39.5
x
|
32
x
|
Yield
|
0.43%
|
0.39%
|
0.43%
|
0.33%
|
0.39%
|
0.34%
|
0.38%
|
0.47%
|
Capitalization / Revenue
|
7.62
x
|
7.69
x
|
15.1
x
|
12.4
x
|
8.92
x
|
9.25
x
|
7.4
x
|
6.11
x
|
EV / Revenue
|
7.62
x
|
7.41
x
|
14.9
x
|
12.4
x
|
8.79
x
|
9.25
x
|
7.4
x
|
6.12
x
|
EV / EBITDA
|
20.9
x
|
18.4
x
|
40.3
x
|
46.2
x
|
30.8
x
|
37.5
x
|
28
x
|
23.4
x
|
EV / FCF
|
-1,480
x
|
27.4
x
|
104
x
|
-504
x
|
58.1
x
|
158
x
|
524
x
|
67.2
x
|
FCF Yield
|
-0.07%
|
3.65%
|
0.96%
|
-0.2%
|
1.72%
|
0.63%
|
0.19%
|
1.49%
|
Price to Book
|
8.04
x
|
6.18
x
|
9.32
x
|
11
x
|
8.38
x
|
6.68
x
|
5.77
x
|
5.02
x
|
Nbr of stocks (in thousands)
|
102,782
|
102,782
|
102,782
|
102,782
|
102,782
|
103,666
|
-
|
-
|
Reference price
2 |
822.0
|
769.4
|
1,400
|
1,952
|
1,808
|
1,627
|
1,627
|
1,627
|
Announcement Date
|
5/11/19
|
6/13/20
|
5/13/21
|
5/14/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,081
|
10,289
|
9,543
|
16,155
|
20,847
|
18,239
|
22,797
|
27,583
|
EBITDA
1 |
4,036
|
4,139
|
3,525
|
4,341
|
5,954
|
4,494
|
6,023
|
7,231
|
EBIT
1 |
3,762
|
3,808
|
3,096
|
3,886
|
5,435
|
3,823
|
5,107
|
6,508
|
Operating Margin
|
33.95%
|
37.01%
|
32.45%
|
24.05%
|
26.07%
|
20.96%
|
22.4%
|
23.59%
|
Earnings before Tax (EBT)
1 |
4,252
|
4,247
|
3,353
|
4,493
|
6,153
|
4,180
|
5,753
|
6,922
|
Net income
1 |
2,825
|
3,338
|
2,693
|
3,467
|
4,580
|
3,146
|
4,268
|
5,181
|
Net margin
|
25.49%
|
32.45%
|
28.22%
|
21.46%
|
21.97%
|
17.25%
|
18.72%
|
18.78%
|
EPS
2 |
27.48
|
32.48
|
26.20
|
33.73
|
44.56
|
30.51
|
41.17
|
50.77
|
Free Cash Flow
1 |
-57.1
|
2,780
|
1,367
|
-397.9
|
3,154
|
1,066
|
322.1
|
2,512
|
FCF margin
|
-0.52%
|
27.02%
|
14.33%
|
-2.46%
|
15.13%
|
5.84%
|
1.41%
|
9.11%
|
FCF Conversion (EBITDA)
|
-
|
67.17%
|
38.78%
|
-
|
52.97%
|
23.71%
|
5.35%
|
34.74%
|
FCF Conversion (Net income)
|
-
|
83.28%
|
50.76%
|
-
|
68.87%
|
33.87%
|
7.55%
|
48.48%
|
Dividend per Share
2 |
3.500
|
3.000
|
6.000
|
6.500
|
7.000
|
5.514
|
6.143
|
7.671
|
Announcement Date
|
5/11/19
|
6/13/20
|
5/13/21
|
5/14/22
|
5/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
2,235
|
2,798
|
3,864
|
3,741
|
3,690
|
4,861
|
5,063
|
5,663
|
5,087
|
5,034
|
4,310
|
4,358
|
4,759
|
4,874
|
EBITDA
1 |
721
|
991.2
|
1,015
|
1,010
|
927.7
|
1,388
|
1,309
|
1,485
|
1,638
|
1,523
|
1,090
|
1,090
|
1,109
|
1,235
|
EBIT
1 |
-
|
-
|
-
|
897.4
|
812.6
|
1,271
|
1,181
|
1,354
|
1,507
|
1,393
|
958.1
|
1,086
|
1,034
|
1,049
|
Operating Margin
|
-
|
-
|
-
|
23.99%
|
22.02%
|
26.15%
|
23.32%
|
23.91%
|
29.63%
|
27.67%
|
22.23%
|
24.92%
|
21.73%
|
21.52%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,081
|
1,033
|
959
|
1,420
|
1,363
|
1,554
|
1,675
|
1,561
|
1,109
|
1,125
|
1,030
|
1,100
|
Net income
1 |
641.4
|
708.6
|
809.5
|
813.6
|
832.7
|
1,011
|
1,012
|
1,160
|
1,254
|
1,154
|
832.4
|
858.3
|
837.3
|
861.8
|
Net margin
|
28.7%
|
25.33%
|
20.95%
|
21.75%
|
22.57%
|
20.8%
|
19.99%
|
20.49%
|
24.65%
|
22.92%
|
19.31%
|
19.7%
|
17.59%
|
17.68%
|
EPS
2 |
6.240
|
6.890
|
7.880
|
7.910
|
8.100
|
9.840
|
9.850
|
11.29
|
12.20
|
11.23
|
8.100
|
7.733
|
8.667
|
8.800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/2/21
|
5/13/21
|
7/31/21
|
11/10/21
|
1/31/22
|
5/14/22
|
8/6/22
|
11/7/22
|
2/6/23
|
5/19/23
|
8/11/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
13
|
32
|
240
|
Net Cash position
1 |
-
|
2,830
|
1,995
|
134
|
2,636
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.002892
x
|
0.005313
x
|
0.0332
x
|
Free Cash Flow
1 |
-57.1
|
2,780
|
1,367
|
-398
|
3,154
|
1,066
|
322
|
2,512
|
ROE (net income / shareholders' equity)
|
30.6%
|
28.6%
|
19.1%
|
20.7%
|
22.6%
|
13.3%
|
15.5%
|
16.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
17%
|
18.1%
|
19.8%
|
11.3%
|
-
|
-
|
Assets
1 |
-
|
-
|
15,883
|
19,116
|
23,185
|
27,840
|
-
|
-
|
Book Value Per Share
2 |
102.0
|
124.0
|
150.0
|
177.0
|
216.0
|
244.0
|
282.0
|
324.0
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
-
|
70.50
|
35.20
|
47.60
|
Capex
1 |
2,061
|
1,379
|
822
|
1,669
|
2,626
|
3,637
|
3,443
|
2,067
|
Capex / Sales
|
18.6%
|
13.4%
|
8.61%
|
10.33%
|
12.6%
|
19.94%
|
15.1%
|
7.5%
|
Announcement Date
|
5/11/19
|
6/13/20
|
5/13/21
|
5/14/22
|
5/19/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +14.70% | 64.97B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|